tLyp1 peptide-decorated regulatory T cell-targeted hybrid nanoparticles in combination with anti-CTLA 4 antibody for cancer immunotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최한곤 | - |
dc.date.accessioned | 2021-06-22T11:45:25Z | - |
dc.date.available | 2021-06-22T11:45:25Z | - |
dc.date.issued | 2018-11-22 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/6013 | - |
dc.title | tLyp1 peptide-decorated regulatory T cell-targeted hybrid nanoparticles in combination with anti-CTLA 4 antibody for cancer immunotherapy | - |
dc.type | Conference | - |
dc.citation.conferenceName | 2018 International Conference of The Korean Society of Pharmaceutical Sciences and Technology | - |
dc.citation.conferencePlace | Haeundae Grand Hotel in Busan, Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.